Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae (SIMPLIFY)
Randomized, Multicenter, Phase III, Controlled Clinical Trial, to Demonstrate the no Inferiority of Reduced Antibiotic Treatment vs a Broad Spectrum Betalactam Antipseudomonal Treatment in Patients With Bacteremia by Enterobacteriaceae
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
This PHASE3 trial investigates Enterobacteriaceae Infections and is currently completed. Fundación Pública Andaluza para la gestión de la Investigación en Sevilla leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2019 — Aug 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Spanish Network for Research in Infectious Diseases
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Alicante, Spain , Barakaldo, Spain , Barcelona, Spain , Bormujos, Spain , Cadiz, Spain , Donostia / San Sebastian, Spain , Jerez de la Frontera, Spain , La Línea de la Concepción, Spain , León, Spain and 8 more locations